Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
Open accessThe DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Abstract
Introduction: The initiative of a consensus on the topic of antidepressant and anxiolytic drug use in pregnancy is developing in an area of clinical uncertainty. Although many studies have been published in recent years, there is still a paucity of authoritative evidence-based indications useful for guiding the prescription of these drugs during pregnancy, and the data from the literature are complex and require expert judgment to draw clear conclusions. Methods: For the elaboration of the consensus, we have involved the scientific societies of the sector, namely, the Italian Society of Toxicology, the Italian Society of Neuropsychopharmacology, the Italian Society of Psychiatry, the Italian Society of Obstetrics and Gynecology, the Italian Society of Drug Addiction and the Italian Society of Addiction Pathology. An interdisciplinary team of experts from different medical specialties (toxicologists, pharmacologists, psychiatrists, gynecologists, neonatologists) was first established to identify the needs underlying the consensus. The team, in its definitive structure, includes all the representatives of the aforementioned scientific societies; the task of the team was the evaluation of the most accredited international literature as well as using the methodology of the “Nominal Group Technique” with the help of a systematic review of the literature and with various discussion meetings, to arrive at the drafting and final approval of the document. Results: The following five areas of investigation were identified: (1) The importance of management of anxiety and depressive disorders in pregnancy, identifying the risks associated with untreated maternal depression in pregnancy. (2) The assessment of the overall risk of malformations with the antidepressant and anxiolytic drugs used in pregnancy. (3) The evaluation of neonatal adaptation disorders in the offspring of pregnant antidepressant/anxiolytic-treated women. (4) The long-term outcome of infants’ cognitive development or behavior after in utero exposure to antidepressant/anxiolytic medicines. (5) The evaluation of pharmacological treatment of opioid-abusing pregnant women with depressive disorders. Conclusions: Considering the state of the art, it is therefore necessary in the first instance to frame the issue of pharmacological choices in pregnant women who need treatment with antidepressant and anxiolytic drugs on the basis of data currently available in the literature. Particular attention must be paid to the evaluation of the risk/benefit ratio, understood both in terms of therapeutic benefit with respect to the potential risks of the treatment on the pregnancy and on the fetal outcome, and of the comparative risk between the treatment and the absence of treatment; in the choice prescription, the specialist needs to be aware of both the potential risks of pharmacological treatment and the equally important risks of an untreated or undertreated disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, three guidelines offered explicit advice to use agents such as lorazepam, temazepam, oxazepam or brotizolam, which either undergo limited hepatic metabolism or have relatively shorter elimination half-lives to minimise theoretic fetal or lactational exposure.32,34,55”
From Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review (2024) · cites this paper as [32]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately 20 to 40% of neonates who have been exposed to BZDs in utero during late pregnancy develop neonatal withdrawal, with symptoms including irritability, increased sedation, abnormal muscle tone, poor feeding, sleep problems, and mild respiratory distress.179–183”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [181]
In the citing paper
“BZD treatment specifications were provided more often in the context of perinatal/post-partum depressive disorders.32,34,55”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grote, N. K., Bridge, J. A., Gavin, A. R., Melville, J. L., Iyengar, S., & Katon, W. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.111 · Cited by 1,882 · cited 1×
“Interestingly, in five studies it was noted an increased risk of preterm birth exists for women with depression but without SSRI exposure during pregnancy [129,131,132,146,147].”
BackgroundACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 880
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842 · cited 1×
“Royal Australian and New Zealand College of Psychiatrists, 2015 [187] Australia and New Zealand Advise psychotherapy for new-onset depression”
BackgroundAlterations induced by gestational stress in brain morphology and behaviour of the offspring
Weinstock, M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00018-1 · Cited by 791
Birth Outcomes in Pregnant Women Taking Fluoxetine
Chambers, C. D., Johnson, K. A., Dick, L. M., Felix, R. J., & Jones, K. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351402 · Cited by 735
Depression and anxiety in early pregnancy and risk for preeclampsia
Kurki, T. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(99)00602-x · Cited by 690 · cited 2×
“It has been suggested that psychological conditions, such as stress, anxiety and depression [110,193], may trigger the pathogenic vascular processes that lead to this condition and need to be balanced against the effect induced by the pharmacological treatment.”
BackgroundThe comorbidity of depression and substance use disorders
Swendsen, J. (2000) · Clinical Psychology Review · doi:10.1016/s0272-7358(99)00026-4 · Cited by 632
Jarde, A., Morais, M., Kingston, D., Giallo, R., MacQueen, G. M., Giglia, L., Beyene, J., Wang, Y., & McDonald, S. D. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0934 · Cited by 616
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003892 · Cited by 577
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Moses-Kolko, E. L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B., & Wisner, K. L. (2005) · JAMA · doi:10.1001/jama.293.19.2372 · Cited by 533
Teixeira, J. M. A., Fisk, N. M., & Glover, V. (1999) · BMJ · doi:10.1136/bmj.318.7177.153 · Cited by 526
Antepartum Depressive Symptomatology Is Associated With Adverse Obstetric and Neonatal Outcomes
Chung, T. K. H., Lau, T. K., Yip, A. S. K., Chiu, H. F. K., & Lee, D. T. S. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200109000-00017 · Cited by 501
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Louik, C., Lin, A. E., Werler, M. M., Hernández-Díaz, S., & Mitchell, A. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067407 · Cited by 500
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495 · cited 2×
“Not controlled Alwan et al., 2007 [34] Retrospective case–control study SSRI vs. non-SSRI exposure Paroxetine: Non-significant risk for MM (OR = 1.6; 95% CI 0.9–2.7).”
InfluentialACOG Practice Bulletin No. 200: Early Pregnancy Loss
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002899 · Cited by 483
Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., & Koren, G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1889 · Cited by 441
Fetal Growth Restriction: ACOG Practice Bulletin, Number 227
(2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004251 · Cited by 435
Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
Iqbal, M. M., Sobhan, T., & Ryals, T. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.39 · Cited by 427 · cited 1×
“The case reports of NAS in newborns exposed in utero to benzodiazepines have included descriptions of increased sedation, abnormal muscle tone, poor feeding, sleep problems, poor weight gain, tachypnea, irritability, loose stools, vomiting and vigorous sucking [97,136,148,224].”
BackgroundKulin, N. A., Pastuszak, A., Sage, S. R., Schick-Boschetto, B., Spivey, G., Feldkamp, M., Ormond, K., Matsui, D., Stein-Schechman, A. K., Cook, L., et al. (1998) · JAMA · doi:10.1001/jama.279.8.609 · Cited by 424
Update on overall prevalence of major birth defects - Atlanta, Georgia, 1978-2005: (403792008-002)
(2008) · PsycEXTRA Dataset · doi:10.1037/e403792008-002 · Cited by 409
Casper, R. C., Fleisher, B. E., Lee-Ancajas, J. C., Gilles, A., Gaylor, E., DeBattista, A., & Hoyme, H. E. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.139 · Cited by 408
Antidepressant Use in Pregnancy and the Risk of Cardiac Defects
Huybrechts, K. F., Palmsten, K., Avorn, J., Cohen, L. S., Holmes, L. B., Franklin, J. M., Mogun, H., Levin, R., Kowal, M., Setoguchi, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312828 · Cited by 402
Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes
Wisner, K. L., Sit, D. K. Y., Hanusa, B. H., Moses-Kolko, E. L., Bogen, D. L., Hunker, D. F., Perel, J. M., Jones-Ivy, S., Bodnar, L. M., & Singer, L. T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081170 · Cited by 400
Management of bipolar disorder during pregnancy and the postpartum period
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.608 · Cited by 394 · cited 3×
“When an underlying psychiatric condition was accounted for, the preterm birth risk was reported as significant in 11 studies [72,86,115,127–129, 131,138,140,142,143] and non-significant in 9 studies [67,68,80,125,126,134,137,141,148].”
BackgroundOutcomes of Prenatal Antidepressant Exposure
Simon, G. E., Cunningham, M. L., & Davis, R. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2055 · Cited by 386
Pregnancy Outcome Following First-Trimester Exposure to Fluoxetine (Prozac)
Pastuszak, A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500170076037 · Cited by 368
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.4.602 · Cited by 360
Orr, S. T. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf131 · Cited by 357
Psychosocial factors and pregnancy outcome: A review with emphasis on methodological issues
Paarlberg, K. M., Vingerhoets, A. J. J. M., Passchier, J., Dekker, G. A., & Van Geijn, H. P. (1995) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(95)00018-6 · Cited by 356 · cited 1×
“Concerning untreated depression, many authors have associated it with adverse events in pregnancy, such as spontaneous abortion [189], bleeding during gestation [190], increased uterine artery resistance [191], gestational hypertension and subsequent preeclampsia [192,193], and also in the neonatal period as preterm d…”
BackgroundDolovich, L. R., Addis, A., Vaillancourt, J. M. R., Power, J. D. B., Koren, G., & Einarson, T. R. (1998) · BMJ · doi:10.1136/bmj.317.7162.839 · Cited by 353
Reis, M., & Källén, B. (2010) · Psychological Medicine · doi:10.1017/s0033291709992194 · Cited by 340
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332 · cited 1×
“The pharmacotherapy for substance abuse and addiction has been reviewed in several guidelines [248], and in National Institute for Health and Care Excellence [182] as well as in the Cochrane review of improving pregnancy outcomes [249], and reviews of psychosocial interventions and maintenance programs in pregnant wom…”
MethodLaine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 331
Levinson-Castiel, R., Merlob, P., Linder, N., Sirota, L., & Klinger, G. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.2.173 · Cited by 329
Role of Anxiety and Depression in the Onset of Spontaneous Preterm Labor
Dayan, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.293 · Cited by 322
Hoffman, S., & Hatch, M. C. (2000) · Health Psychology · doi:10.1037//0278-6133.19.6.535 · Cited by 317
Neonate Characteristics After Maternal Use of Antidepressants in Late Pregnancy
Källén, B. (2004) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.158.4.312 · Cited by 300
Pedersen, L. H., Henriksen, T. B., Vestergaard, M., Olsen, J., & Bech, B. H. (2009) · BMJ · doi:10.1136/bmj.b3569 · Cited by 297
Delivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B., & Wiholm, B.-E. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284
Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior
Zeskind, P. S., & Stephens, L. E. (2004) · Pediatrics · doi:10.1542/peds.113.2.368 · Cited by 280
Kieler, H., Artama, M., Engeland, A., Ericsson, O., Furu, K., Gissler, M., Nielsen, R. B., Norgaard, M., Stephansson, O., Valdimarsdottir, U., et al. (2011) · BMJ · doi:10.1136/bmj.d8012 · Cited by 277
Bérard, A., Ramos, É., Rey, É., Blais, L., St.‐André, M., & Oraichi, D. (2007) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20099 · Cited by 275
Källén, B. A. J., & Otterblad Olausson, P. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20327 · Cited by 270
Perinatal Outcome Following Third Trimester Exposure to Paroxetine
Costei, A. M., Kozer, E., Ho, T., Ito, S., & Koren, G. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.11.1129 · Cited by 270
Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn
Huybrechts, K. F., Bateman, B. T., Palmsten, K., Desai, R. J., Patorno, E., Gopalakrishnan, C., Levin, R., Mogun, H., & Hernandez-Diaz, S. (2015) · JAMA · doi:10.1001/jama.2015.5605 · Cited by 254
Wikner, B. N., Stiller, C., Bergman, U., Asker, C., & Källén, B. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1457 · Cited by 253
MacQueen, G. M., Frey, B. N., Ismail, Z., Jaworska, N., Steiner, M., Lieshout, R. J. V., Kennedy, S. H., Lam, R. W., Milev, R. V., Parikh, S. V., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659276 · Cited by 248
Suri, R., Altshuler, L., Hellemann, G., Burt, V. K., Aquino, A., & Mintz, J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06071172 · Cited by 247
ACOG Practice Bulletin No. 92: Use of Psychiatric Medications During Pregnancy and Lactation
(2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31816fd910 · Cited by 246
Etiology and clinical presentation of birth defects: population based study
Feldkamp, M. L., Carey, J. C., Byrne, J. L. B., Krikov, S., & Botto, L. D. (2017) · BMJ · doi:10.1136/bmj.j2249 · Cited by 245
Oberlander, T. F., Misri, S., Fitzgerald, C. E., Kostaras, X., Rurak, D., & Riggs, W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0214 · Cited by 244
Einarson, A., Fatoye, B., Sarkar, M., Lavigne, S. V., Brochu, J., Chambers, C., Mastroiacovo, P., Addis, A., Matsui, D., Schuler, L., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1728 · Cited by 240
Zedler, B. K., Mann, A. L., Kim, M. M., Amick, H. R., Joyce, A. R., Murrelle, E. L., & Jones, H. E. (2016) · Addiction · doi:10.1111/add.13462 · Cited by 240
Selective serotonin reuptake inhibitors and adverse pregnancy outcomes
Wen, S. W., Yang, Q., Garner, P., Fraser, W., Olatunbosun, O., Nimrod, C., & Walker, M. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.02.019 · Cited by 234
Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study
Chun-Fai-Chan, B., Koren, G., Fayez, I., Kalra, S., Voyer-Lavigne, S., Boshier, A., Shakir, S., & Einarson, A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.09.027 · Cited by 234
Einarson, T. R., & Einarson, A. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1084 · Cited by 230
Bar-Oz, B., Einarson, T., Einarson, A., Boskovic, R., O'Brien, L., Malm, H., Bérard, A., & Koren, G. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.003 · Cited by 226
Sujan, A. C., Rickert, M. E., Öberg, A. S., Quinn, P. D., Hernández-Díaz, S., Almqvist, C., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017) · JAMA · doi:10.1001/jama.2017.3413 · Cited by 226
Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
Malm, H., Artama, M., Gissler, M., & Ritvanen, A. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318220edcc · Cited by 213
Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
Malm, H., Klaukka, T., & Neuvonen, P. J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187302.61812.53 · Cited by 211
Birth outcomes after prenatal exposure to antidepressant medication
Hendrick, V., Smith, L. M., Suri, R., Hwang, S., Haynes, D., & Altshuler, L. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.172 · Cited by 209
Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study
Diav‐Citrin, O., Shechtman, S., Weinbaum, D., Wajnberg, R., Avgil, M., Di Gianantonio, E., Clementi, M., Weber‐Schoendorfer, C., Schaefer, C., & Ornoy, A. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03261.x · Cited by 207
Internalizing Behaviors in 4-Year-Old Children Exposed in Utero to Psychotropic Medications
Misri, S., Reebye, P., Kendrick, K., Carter, D., Ryan, D., Grunau, R. E., & Oberlander, T. F. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.1026 · Cited by 207 · cited 1×
“Population-based and crosssectional studies showed that maternal depressive symptoms, rather than prenatal SSRI exposure, were related to higher levels of internalizing behavior [235,236] or higher levels of conduct and social problems in children [237].”
BackgroundKällén, B., & Olausson, P. O. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1570 · Cited by 205
Davis, R. L., Rubanowice, D., McPhillips, H., Raebel, M. A., Andrade, S. E., Smith, D., Yood, M. U., & Platt, R. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1462 · Cited by 203
Maternal drug use in early pregnancy and infant cardiovascular defect
KALLEN, B. (2003) · Reproductive Toxicology · doi:10.1016/s0890-6238(03)00012-1 · Cited by 202
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Tomlinson, G., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., & Ross, L. E. (2014) · BMJ · doi:10.1136/bmj.f6932 · Cited by 197
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn
Andrade, S. E., McPhillips, H., Loren, D., Raebel, M. A., Lane, K., Livingston, J., Boudreau, D. M., Smith, D. H., Davis, R. L., Willy, M. E., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1710 · Cited by 195
Lattimore, K. A., Donn, S. M., Kaciroti, N., Kemper, A. R., Neal, C. R., & Vazquez, D. M. (2005) · Journal of Perinatology · doi:10.1038/sj.jp.7211352 · Cited by 189 · cited 4×
“, 2005 [130] Meta-analysis of prospective cohort studies SSRI (III trimester exposure) Non-significant PNA risk (OR = 4.”
BackgroundInfluentialOberlander, T. F., Warburton, W., Misri, S., Riggs, W., Aghajanian, J., & Hertzman, C. (2008) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20144 · Cited by 187
Nulman, I., Koren, G., Rovet, J., Barrera, M., Pulver, A., Streiner, D., & Feldman, B. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11111721 · Cited by 186
Einarson, A., Pistelli, A., DeSantis, M., Malm, H., Paulus, W. D., Panchaud, Kennedy, D., Einarson, T. R., & Koren, G. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07060879 · Cited by 186
Self-citationFuru, K., Kieler, H., Haglund, B., Engeland, A., Selmer, R., Stephansson, O., Valdimarsdottir, U. A., Zoega, H., Artama, M., Gissler, M., et al. (2015) · BMJ · doi:10.1136/bmj.h1798 · Cited by 185
Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P. B., Lipworth, L., & Sørensen, H. T. (2006) · Epidemiology · doi:10.1097/01.ede.0000239581.76793.ae · Cited by 185
Grigoriadis, S., VonderPorten, E. H., Mamisashvili, L., Roerecke, M., Rehm, J., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., et al. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07966 · Cited by 181
Gestational Diabetes Mellitus in Europe: A Systematic Review and Meta-Analysis of Prevalence Studies
Paulo, M. S., Abdo, N. M., Bettencourt-Silva, R., & Al-Rifai, R. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.691033 · Cited by 181 · cited 1×
“In Europe, gestational diabetes mellitus is significant in pregnant women, around 11% of all pregnancies [209].”
BackgroundAntidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis
Hemels, M. E., Einarson, A., Koren, G., Lanctôt, K. L., & Einarson, T. R. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e547 · Cited by 179
Minozzi, S., Amato, L., & Davoli, M. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04005.x · Cited by 174
Use of antidepressants during pregnancy and the risk of spontaneous abortion
Nakhai-Pour, H. R., Broy, P., & Berard, A. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091208 · Cited by 169
Postpartum Hemorrhage Trends and Outcomes in the United States, 2000–2019
Corbetta-Rastelli, C. M., Friedman, A. M., Sobhani, N. C., Arditi, B., Goffman, D., & Wen, T. (2023) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004972 · Cited by 165
Einarson, A., Choi, J., Einarson, T. R., & Koren, G. (2009) · The Canadian Journal of Psychiatry · doi:10.1177/070674370905400405 · Cited by 163
Paroxetine in the first trimester and the prevalence of congenital malformations
Cole, J. A., Ephross, S. A., Cosmatos, I. S., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1463 · Cited by 162
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy
Suarez, E. A., Huybrechts, K. F., Straub, L., Hernández-Díaz, S., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B., Terplan, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203318 · Cited by 162
Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy
Wichman, C. L., Moore, K. M., Lang, T. R., Sauver, J. L. S., Heise, R. H., & Watson, W. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.1.23 · Cited by 157
Anderson, K. N., Lind, J. N., Simeone, R. M., Bobo, W. V., Mitchell, A. A., Riehle‐Colarusso, T. J., Polen, K. N. D., & Reefhuis, J. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2453 · Cited by 156
Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
Lund, N., Pedersen, L. H., & Henriksen, T. B. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.164 · Cited by 153
Gao, S.-Y., Wu, Q.-J., Sun, C., Zhang, T.-N., Shen, Z.-Q., Liu, C.-X., Gong, T.-T., Xu, X., Ji, C., Huang, D.-H., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1193-5 · Cited by 152
Rahimi, R., Nikfar, S., & Abdollahi, M. R. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2006.03.019 · Cited by 151
Bupropion in pregnancy and the prevalence of congenital malformations
Cole, J. A., Modell, J. G., Haight, B. R., Cosmatos, I. S., Stoler, J. M., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1296 · Cited by 149 · cited 3×
“, 2007 [93] Retrospective registry-based cohort study Bupropion (I trimester exposure) Non-significant congenital MM risk (aOR = 0.”
BackgroundResultBérard, A., Zhao, J.-P., & Sheehy, O. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013372 · Cited by 148
Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome
Sivojelezova, A., Shuhaiber, S., Sarkissian, L., Einarson, A., & Koren, G. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.05.012 · Cited by 146
Order of onset of substance abuse and depression in a sample of depressed outpatients
Abraham, H. D., & D, M. F. M. (1999) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(99)90076-7 · Cited by 146
Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age
Pedersen, L. H., Henriksen, T. B., & Olsen, J. (2010) · Pediatrics · doi:10.1542/peds.2008-3655 · Cited by 144 · cited 2×
“Population-based and crosssectional studies showed that maternal depressive symptoms, rather than prenatal SSRI exposure, were related to higher levels of internalizing behavior [235,236] or higher levels of conduct and social problems in children [237].”
BackgroundEke, A., Saccone, G., & Berghella, V (2016) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14144 · Cited by 143
Jimenez-Solem, E., Andersen, J. T., Petersen, M., Broedbaek, K., Jensen, J. K., Afzal, S., Gislason, G. H., Torp-Pedersen, C., & Poulsen, H. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001148 · Cited by 139
Einarson, A., Bonari, L., Voyer-Lavigne, S., Addis, A., Matsui, D., Johnson, Y., & Koren, G. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800207 · Cited by 139
Exposure to Mirtazapine During Pregnancy: A Prospective, Comparative Study of Birth Outcomes
Djulus, J., Koren, G., Einarson, T. R., Wilton, L., Shakir, S., Diav-Citrin, O., Kennedy, D., Voyer Lavigne, S., De Santis, M., & Einarson, A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0817 · Cited by 138
Malm, H., Sourander, A., Gissler, M., Gyllenberg, D., Hinkka-Yli-Salomäki, S., McKeague, I. W., Artama, M., & Brown, A. S. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14121575 · Cited by 136
Ferreira, E., Carceller, A. M., Agogué, C., Martin, B. Z., St-André, M., Francoeur, D., & Bérard, A. (2007) · Pediatrics · doi:10.1542/peds.2006-2133 · Cited by 135
Methadone in pregnancy: treatment retention and neonatal outcomes
Burns, L., Mattick, R. P., Lim, K., & Wallace, C. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01651.x · Cited by 135
Maintenance agonist treatments for opiate dependent pregnant women
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub2 · Cited by 134
Nordeng, H., van Gelder, M. M. H. J., Spigset, O., Koren, G., Einarson, A., & Eberhard-Gran, M. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182490eaf · Cited by 133
Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants
Lennestål, R., & Källén, B. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4d2 · Cited by 129
Warburton, W., Hertzman, C., & Oberlander, T. F. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01490.x · Cited by 128
Antidepressants in pregnancy: a systematic review.
(2010) · PubMed · doi:10.3109/00048674.2010.507543 · Cited by 128 · cited 1×
“, 2010 [179] Systematic review Antidepressant (SSRI, SNRI, TCAs, other) Large database or registry studies: Higher risk of neonatal adaptation difficulties, 1.”
BackgroundMyles, N., Newall, H., Ward, H., & Large, M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413492219 · Cited by 126
Motherisk Rounds: The Fetal Safety of Benzodiazepines: An Updated Meta-analysis
Enato, E. F. O., Moretti, M. E., & Koren, G. (2011) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34772-7 · Cited by 123
Lugo-Candelas, C., Cha, J., Hong, S., Bastidas, V., Weissman, M., Fifer, W. P., Myers, M., Talati, A., Bansal, R., Peterson, B. S., et al. (2018) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.5227 · Cited by 119
Marroun, H. E., White, T. J. H., van der Knaap, N. J. F., Homberg, J. R., Fernández, G., Schoemaker, N. K., Jaddoe, V. W. V., Hofman, A., Verhulst, F. C., Hudziak, J. J., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.127746 · Cited by 117 · cited 3×
“When an underlying psychiatric condition was accounted for, the preterm birth risk was reported as significant in 11 studies [72,86,115,127–129, 131,138,140,142,143] and non-significant in 9 studies [67,68,80,125,126,134,137,141,148].”
BackgroundResultBakker, M. K., Kerstjens‐Frederikse, W. S., Buys, C. H. C. M., de Walle, H. E. K., & de Jong‐van den Berg, L. T. W. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20641 · Cited by 117
Krinzinger, H., Hall, C. L., Groom, M. J., Ansari, M. T., Banaschewski, T., Buitelaar, J. K., Carucci, S., Coghill, D., Danckaerts, M., Dittmann, R. W., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.023 · Cited by 117
Wilson, K., Zelig, C., Harvey, J., Cunningham, B., Dolinsky, B., & Napolitano, P. (2011) · American Journal of Perinatology · doi:10.1055/s-0030-1262507 · Cited by 116
Effects of Third Trimester Fluoxetine Exposure on the Newborn
Goldstein, D. J. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199512000-00005 · Cited by 115
Calderon-Margalit, R., Qiu, C., Ornoy, A., Siscovick, D. S., & Williams, M. A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.06.061 · Cited by 115
Birth outcomes in the offspring of mentally disordered women.
Zax, M., Sameroff, A. J., & Babigian, H. M. (1977) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1977.tb00977.x · Cited by 114
Kornum (2010) · Clinical Epidemiology · doi:10.2147/clep.s9256 · Cited by 112
Qiu, C., Sanchez, S. E., Lam, N., Garcia, P., & Williams, M. A. (2007) · BMC Women's Health · doi:10.1186/1472-6874-7-15 · Cited by 111
Increased Risk of Adverse Pregnancy Outcomes in Women Receiving Zolpidem During Pregnancy
Wang, L.-H., Lin, H.-C., Lin, C.-C., Chen, Y.-H., & Lin, H.-C. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.97 · Cited by 107
Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion – A Population-Based Study
Kjaersgaard, M. I. S., Parner, E. T., Vestergaard, M., Sørensen, M. J., Olsen, J., Christensen, J., Bech, B. H., & Pedersen, L. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072095 · Cited by 107
Antidepressant Use and Risk for Preeclampsia
Palmsten, K., Huybrechts, K. F., Michels, K. B., Williams, P. L., Mogun, H., Setoguchi, S., & Hernández-Díaz, S. (2013) · Epidemiology · doi:10.1097/ede.0b013e31829e0aaa · Cited by 106
Ban, L., Gibson, J., West, J., Fiaschi, L., Sokal, R., Smeeth, L., Doyle, P., Hubbard, R., & Tata, L. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12682 · Cited by 105
Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension
Toh, S., Mitchell, A. A., Louik, C., Werler, M. M., Chambers, C. D., & Hernández-Díaz, S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08060817 · Cited by 104
Bérard, A., Iessa, N., Chaabane, S., Muanda, F. T., Boukhris, T., & Zhao, J. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12849 · Cited by 103
Persistent Pulmonary Hypertension of the Newborn
Ostrea, E. M., Villanueva-Uy, M. E. T., Natarajan, G., & Uy, H. G. (2006) · Pediatric Drugs · doi:10.2165/00148581-200608030-00004 · Cited by 102
The use of psychotropic medication during pregnancy: how about the newborn?
Kieviet, N., Honig, & Dolman (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s36394 · Cited by 100 · cited 2×
“These symptoms are usually mild and transient [163,164].”
BackgroundIs benzodiazepine use during pregnancy really teratogenic?
Ornoy, A., Arnon, J., Shechtman, S., Moerman, L., & Lukashova, I. (1998) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00035-5 · Cited by 100
Koren, G. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041100 · Cited by 100
S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression - Langfassung, 2. Auflage
Deutsche Gesellschaft Für Psychiatrie Und Psychotherapie, P. U. N. (. B. (. K. B. (. A. D. W. M. F. (., & (ÄZQ), Ä. Z. F. Q. I. D. M. (2015) · Ärztliches Zentrum für Qualität in der Medizin · doi:10.6101/azq/000364 · Cited by 99
Association of opioid misuse with anxiety and depression: A systematic review of the literature
Rogers, A. H., Zvolensky, M. J., Ditre, J. W., Buckner, J. D., & Asmundson, G. J. G. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.101978 · Cited by 97
Wemakor, A., Casson, K., Garne, E., Bakker, M. K., Addor, M., Arriola, L., Gatt, M., Khoshnood, B., Klungsøyr, K., Nelen, V., et al. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0065-y · Cited by 96
Maternal use of bupropion and risk for congenital heart defects
Alwan, S. S., Reefhuis, J., Botto, L. D., Rasmussen, S. A., Correa, A., & Friedman, J. M. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.02.015 · Cited by 96
Erős, E., Czeizel, A. E., Rockenbauer, M., Sørensen, H. T., & Olsen, J. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00545-0 · Cited by 96
Ban, L., West, J., Gibson, J. E., Fiaschi, L., Sokal, R., Doyle, P., Hubbard, R., Smeeth, L., & Tata, L. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100996 · Cited by 94
Colvin, L., Slack‐Smith, L., Stanley, F. J., & Bower, C. (2011) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20773 · Cited by 93
Routine pre-pregnancy health promotion for improving pregnancy outcomes
Whitworth, M., & Dowswell, T. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007536.pub2 · Cited by 92 · cited 1×
“The pharmacotherapy for substance abuse and addiction has been reviewed in several guidelines [248], and in National Institute for Health and Care Excellence [182] as well as in the Cochrane review of improving pregnancy outcomes [249], and reviews of psychosocial interventions and maintenance programs in pregnant wom…”
MethodMasarwa, R., Bar-Oz, B., Gorelik, E., Reif, S., Perlman, A., & Matok, I. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.08.030 · Cited by 92
Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy
Nörby, U., Forsberg, L., Wide, K., Sjörs, G., Winbladh, B., & Källén, K. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0181 · Cited by 90
Vlenterie, R., van Gelder, M. M. H. J., Anderson, H. R., Andersson, L., Broekman, B. F. P., Dubnov‐Raz, G., Marroun, H. E., Ferreira, E., Fransson, E., der Heijden, F. M. M. A. V., et al. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004538 · Cited by 90
Duration of antidepressant use during pregnancy and risk of major congenital malformations
Ramos, É., St-André, M., Rey, É., Oraichi, D., & Bérard, A. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.042523 · Cited by 89
Millard, S. J., Weston–Green, K., & Newell, K. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.008 · Cited by 87
Persistent pulmonary hypertension of the newborn
Mandell, E. W., Kinsella, J. P., & Abman, S. H. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.25073 · Cited by 87
Salisbury, A. L., O’Grady, K. E., Battle, C. L., Wisner, K. L., Anderson, G. M., Stroud, L. R., Miller-Loncar, C. L., Young, M. E., & Lester, B. M. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14080989 · Cited by 85
Polen, K. N. D., Rasmussen, S. A., Riehle‐Colarusso, T. J., Reefhuis, J., & Study, A. T. N. B. D. P. (2012) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23096 · Cited by 85
Tosato, S., Albert, U., Tomassi, S., Iasevoli, F., Carmassi, C., Ferrari, S., Nanni, M. G., Nivoli, A., Volpe, U., Atti, A. R., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15r10483 · Cited by 85
Self-citationPrenatal anger effects on the fetus and neonate
Field, T., Diego, M., Hernandez-Reif, M., Salman, F., Schanberg, S., Kuhn, C., Yando, R., & Bendell, D. (2002) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610220130526 · Cited by 84
Einarson, A., Choi, J. J., Einarson, T. R., & Koren, G. (2009) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34177-9 · Cited by 83
Lassen, D., Ennis, Z. N., & Damkier, P. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12497 · Cited by 81
Maschi, S., Clavenna, A., Campi, R., Schiavetti, B., Bernat, M., & Bonati, M. (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01518.x · Cited by 80
Merlob, P., Birk, E., Sirota, L., Linder, N., Berant, M., Stahl, B., & Klinger, G. (2009) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20615 · Cited by 78
The association between depression, anxiety and substance use among Canadian post-secondary students
Esmaeelzadeh, S., Moraros, J., Thorpe, L., & Bird, Y. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s187419 · Cited by 77
Obstetric complications in patients with depression — a population-based case–control study
Preti, A., Cardascia, L., Zen, T., Pellizzari, P., Marchetti, M., Favaretto, G., & Miotto, P. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00185-8 · Cited by 76
Jordan, S. E., Morris, J. K., Davies, G. I., Tucker, D., Thayer, D. S., Luteijn, M., Morgan, M., Garne, E., Hansen, A. V., Klungsøyr, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165122 · Cited by 75
Are Hypnotic Benzodiazepine Receptor Agonists Teratogenic in Humans?
Wikner, B. N., & Källén, B. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182197055 · Cited by 72
Grigoriadis, S., Graves, L. E., Peer, M., Mamisashvili, L., Ruthirakuhan, M. T., Chan, P., Hennawy, M., Parikh, S., Vigod, S. N., Dennis, C., et al. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720904860 · Cited by 72
Maintenance agonist treatments for opiate-dependent pregnant women
Minozzi, S., Amato, L., Jahanfar, S., Bellisario, C., Ferri, M., & Davoli, M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub4 · Cited by 72
Salkeld, E., Ferris, L. E., & Juurlink, D. N. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166c52e · Cited by 71
Gemmel, M., Bögi, E., Ragan, C. M., Hazlett, M. F., Dubovický, M., van den Hove, D., Oberlander, T. F., Charlier, T. D., & Pawluski, J. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.023 · Cited by 70
Grigoriadis, S., Graves, L. E., Peer, M., Mamisashvili, L., Dennis, C., Vigod, S. N., Steiner, M. S., Brown, C., Cheung, A., Dawson, H., et al. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18r12412 · Cited by 70
Antidepressant use during pregnancy and the risk of pregnancy‐induced hypertension
De Vera, M. A., & Bérard, A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04196.x · Cited by 69
Forsberg, L., Navér, L., Gustafsson, L. L., & Wide, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111327 · Cited by 69
Opioid Withdrawal Syndrome: Emerging Concepts and Novel Therapeutic Targets
Rehni, A. K., Jaggi, A. S., & Singh, N. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010017 · Cited by 68
Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study
Huybrechts, K. F., Bateman, B. T., Pawar, A. M., Bessette, L. G., Mogun, H., Levin, R., Hu, L., Motsko, S. P., Fernandes, M. F. S., Upadhyaya, H. P., et al. (2020) · BMJ · doi:10.1136/bmj.m237 · Cited by 67
Kautzky, A., Slamanig, R., Unger, A., & Höflich, A. S. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13367 · Cited by 65
First-Trimester Exposure to Methylphenidate: A Population-Based Cohort Study
Pottegård, A., Hallas, J., Andersen, J. T., Løkkegaard, E. C. L., Dideriksen, D., Aagaard, L., & Damkier, P. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08708 · Cited by 63
Vries, C. D., Gadzhanova, S., Sykes, M. J., Ward, M., & Roughead, E. E. (2020) · Drug Safety · doi:10.1007/s40264-020-01027-x · Cited by 63
Occhiogrosso, M., Omran, S. S., & Altemus, M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11040553 · Cited by 62
Maternal Psychological Stress/Depression and Low Birth Weight: Is There a Relationship?
McAnarney, E. R. (1990) · American Journal of Diseases of Children · doi:10.1001/archpedi.1990.02150310057027 · Cited by 60
Galbally, M., Lewis, A. J., Lum, J., & Buist, A. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903107583 · Cited by 59
Sanlorenzo, L. A., Cooper, W. O., Dudley, J. A., Stratton, S. M., Maalouf, F. I., & Patrick, S. W. (2019) · Hospital Pediatrics · doi:10.1542/hpeds.2018-0227 · Cited by 59
Lewis, A. J., Galbally, M., Opie, G., & Buist, A. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903559593 · Cited by 57
Birth Outcomes Following Prenatal Exposure to Antidepressants
Pearson, K. H., Nonacs, R. M., Viguera, A. C., Heller, V. L., Petrillo, L. F., Brandes, M., Hennen, J., & Cohen, L. S. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0817 · Cited by 56
Does Paroxetine Cause Cardiac Malformations?
O’Brien, L., Einarson, T. R., Sarkar, M., Einarson, A., & Koren, G. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32918-8 · Cited by 56
Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study
Klieger‐Grossmann, C., Weitzner, B., Panchaud, A., Pistelli, A., Einarson, T., Koren, G., & Einarson, A. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011405524 · Cited by 56
Self-citationBellantuono, C., Vargas, M., Mandarelli, G., Nardi, B., & Martini, M. G. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2473 · Cited by 55
Noh, Y., Lee, H., Choi, A., Kwon, J. S., Choe, S., Chae, J., Kim, D., & Shin, J. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003945 · Cited by 55
Nikfar, S., Rahimi, R., Hendoiee, N., & Abdollahi, M. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-75 · Cited by 54
Ornoy, A., & Koren, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102370 · Cited by 54
Bayrampour, H., Kapoor, A., Bunka, M., & Ryan, D. (2020) · Journal of Clinical Psychiatry · doi:10.4088/jcp.19r13134 · Cited by 54
Biffi, A., Cantarutti, A., Rea, F., Locatelli, A., Zanini, R., & Corrao, G. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.02.023 · Cited by 53
Wang, S., Yang, L., Wang, L., Gao, L., Xu, B., & Xiong, Y. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001681 · Cited by 51
Reis, M., & Källén, B. A. J. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002166 · Cited by 51
Grzeskowiak, L. E., Morrison, J. L., Henriksen, T. B., Bech, B. H., Obel, C., Olsen, J., & Pedersen, L. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13611 · Cited by 50
Boucher, N., Bairam, A., & Beaulac-Baillargeon, L. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173aa2e · Cited by 50
Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.
Klinger, G., & Merlob, P. (2008) · PubMed · Cited by 49
MOTHERISK ROUNDS: The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis
Riggin, L., Frankel, Z., Moretti, M. E., Pupco, A., & Koren, G. (2013) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30965-8 · Cited by 49
Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors
Grzeskowiak, L. E., Gilbert, A. L., & Morrison, J. L. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31826686bc · Cited by 49
Gavin, A. R., Holzman, C., Siefert, K., & Tian, Y. (2009) · Women's Health Issues · doi:10.1016/j.whi.2009.05.004 · Cited by 48
Shen, Z., Gao, S., Li, S. X., Zhang, T., Liu, C., Lv, H., Zhang, Y., Gong, T., Xu, X., Ji, C., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13161 · Cited by 48
Ng, Q. X., Venkatanarayanan, N., Ho, C. Y. X., Sim, W. S., Lim, D. Y., & Yeo, W. S. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.7319 · Cited by 47
Tinker, S. C., Reefhuis, J., Bitsko, R. H., Gilboa, S. M., Mitchell, A. A., Tran, E. L., Werler, M. M., Broussard, C. S., & Study, T. N. B. D. P. (2019) · Birth Defects Research · doi:10.1002/bdr2.1497 · Cited by 47
Wang, J., & Cosci, F. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000516031 · Cited by 47
Hilli, J., Heikkinen, T., Rontu, R., Lehtimäki, T. J., Kishida, I., Aklillu, E., Bertilsson, L., Vahlberg, T. J., & Laine, K. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.006 · Cited by 46
Lindqvist, P. G., Nasiell, J., Gustafsson, L. L., & Nordström, L. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12757 · Cited by 46
Antidepressant medication use, depression, and the risk of preeclampsia
Avalos, L. A., Chen, H., & Li, D.-K. (2015) · CNS Spectrums · doi:10.1017/s1092852915000024 · Cited by 46
Methylphenidate in Pregnancy: A Multicenter, Prospective, Comparative, Observational Study
Diav-Citrin, O., Shechtman, S., Arnon, J., Wajnberg, R., Borisch, C., Beck, E., Richardson, J. L., Bozzo, P., Nulman, I., & Ornoy, A. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10083 · Cited by 46
(2015) · PubMed Central · Cited by 45
Research works printed but not linked: 3
- Anbalagan S. Mendez M.D. Neonatal Abstinence Syndrome StatPearls Treasure Island, FL, USA 2023 31855342
- Schloemp S. Paulus W.E. Sterzik K. Stoz F. Congenital malformations after antidepressant medication with paroxetine in early pregnancy? Hum. Reprod. 2006 21 (Suppl. 1) i12
- National Institute for Health and Care Excellence (NICE) Surveillance of Pregnancy and Complex Social Factors: A Model for Service Provision for Pregnant Women with Complex Social Factors (NICE Guideline CG110) National Institute for Health and Care Excellence (NICE) London, UK 2018 Bookshelf ID: NBK551070 31855334
Cited by
Vigod, S. N., Frey, B. N., Clark, C. T., Grigoriadis, S., Barker, L. C., Brown, H. K., Charlebois, J., Dennis, C., Fairbrother, N., Green, S. M., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241303031 · Cited by 117
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Brunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
Eleftheriou, G., Callegher, R. Z., Butera, R., Santis, M. D., Cavaliere, A. F., Vecchio, S., Lanzi, C., Davanzo, R., Mangili, G., Bondi, E., et al. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21050551 · Cited by 36
Self-citationManagement of Bipolar Disorder in Pregnancy and Postpartum: A Clinicians’ Guide
Bergink, V., Suleiman, M., Hennen, M., & Robakis, T. K. (2025) · CNS Drugs · doi:10.1007/s40263-025-01202-7 · Cited by 15
Metadata
- Authors
- Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., Gallo, M., Balestrieri, M., & Albert, U.
- Affiliations
- Ospedale Papa Giovanni XXIII (IT)
- Italian Society of Psychiatry (SIP), piazza Santa Maria della Pietà 5, 00135 Rome, Italy
- Italian Society of Obstetrics and Gynecology (SIGO), via di Porta Pinciana 6, 00187 Rome, Italy
- Italian Society of Toxicology (SITOX), via Giovanni Pascoli 3, 20129 Milan, Italy
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Ser.D Biella—Drug Addiction Service, 13875 Biella, Italy
- University of Udine (IT)
- University of Trieste (IT)
- Corresponding author
- Eleftheriou, Georgios
- ORCID
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2023-08-11
- Volume
- 20
- Issue
- 16
- Pages
- 6565
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC10454549
- OpenAlex
- W4385759437
- Cited by
- 17
- References
- 262
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 2
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- antidepressant use in pregnancy, fetal malformations, infant cognitive development, opioid use disorder in pregnancy, risk-benefit assessment, consensus recommendations, prenatal drug exposure, neonatal abstinence syndrome, maternal and fetal outcomes
- MeSH terms
- Clinical Decision-Making, Depressive Disorder, Female, Humans, Infant, Infant, Newborn, Pregnancy, Psychiatry, Anti-Anxiety Agents, Uncertainty, Pregnant People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.